Gore & Associates announced FDA approval of an expanded indication for the company’s Viabahn VBX balloon expandable e ...

FEVAR and BEVAR transformed how complex aortic aneurysms are treated. Clinicians now have an FDA-approved bridging stent option specifically indicated for these procedures.

Approval brings U.S. vascular surgeons the first on-label bridging stent graft for both fenestrated and branched endovascular aortic repair, as three-year clinical outcomes demonstrate safety and ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Aortica Corporation today announced that Dr. Benjamin Starnes, Chief of Vascular Surgery at the University of Washington (UW), completed the first 3-vessel ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Aortica Corp. today announced the publication of study results in the Journal of Vascular Surgery (JVS) demonstrating the successful use of their investigational ...

Vadodara: A 67-year-old man with an aortic aneurysm (ballooning of the abdominal aorta) successfully underwent fenestrated endovascular aortic aneurysm repair (FEVAR) in the city. The patient had a ...

Fenestrated endovascular abdominal aortic aneurysm repair (FEVAR) is associated with higher rates of transfusion and postoperative complications compared with standard EVAR, according to a study ...

The expanded indication covers the device’s use as a bridging stent in fenestrated and branched aortic repair.

Gore today announced US Food and Drug Administration (FDA) approval of an expanded indication for the company's Viabahn VBX ...